Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is... see more

TSX:CRDL - Post Discussion

Cardiol Therapeutics Inc > Why CRDL is up today...,
View:
Post by Youhillman on Feb 03, 2021 10:37am

Why CRDL is up today...,

Love the jump in share price today...IMO the news about GW Pharma is the catalyst.


https://ca.finance.yahoo.com/news/jazz-pharmaceuticals-buy-gw-7-125007918.html

Comment by realitytester on Feb 03, 2021 11:30am
Amazing news! Can't wait to hear more from Cardiol!!!! 
Comment by bullmarketnow on Feb 03, 2021 11:55am
Have a look at GW Pham
Comment by Mapleleaf57 on Feb 03, 2021 5:37pm
It has nothing to do about GW Pharma,,,, some big shot in the USA is promoting CRDL,, that is why it went up today,,, wait till they find out what type of company this really is , and Im sure it will go below $3 again
Comment by Youhillman on Feb 03, 2021 5:50pm
Looks like Maplelaugh57 got caught with their 'shorts' down......NO big shot drove the SP up today, without a doubt it was the news regarding GW Pharma! You can take that to the bank and that's exactly what I'm doing today with all the profits I made MapleLaugh57!  
Comment by Youhillman on Feb 03, 2021 6:29pm
FYI....Steve Grasso...who many think is a 'big shot'.....I personally think he knows what he's doing...just put out a tweet 7 minutes ago...about the GW Pharma deal....and to take a look at CRDL....just putting it out there before the naysayers do....
Comment by realitytester on Feb 03, 2021 9:06pm
Thanks for your post.  I think the gw pharma buy out deal got cardiol attention. Excited to see what tomorrow brings, been an investor for close to 2 years now. It would be great to see news tomorrow re: phase 1 myocarditis study results. 
Comment by Youhillman on Feb 03, 2021 9:42pm
You're welcome!...look at what Grasso put out...that's just reinforces why the SP shot up today! IMO....I don't think Phase one of AM moves the dial much, primarily due to how far along they are with phase 2/3 of Covid, which is very much the same type of condition, just different causes. I believe the next major catalyst will be results at Shoppers or new agreements for distribution ...more  
Comment by Youhillman on Feb 03, 2021 11:12pm
Grasso just put out another tweet this evening, sharing a video that Elsley did regarding GW Pharma, if there's any doubt about what moved the needle today in terms of the share price, this puts an end to the discussion!  So many things to like about CRDL, the market potential is huge! https://youtu.be/3xCfwXx4HE0
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities